Sharps Technology, Inc. (STSS) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Instruments & Supplies industria. La empresa tiene su sede en Melville, NY, United States. El CEO actual es Paul Kruger Danner.
STSS tiene fecha de IPO 2022-04-14, 55 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $44.4M.
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
